EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Relapse After Treatment Withdrawal in Autoimmune Hepatitis: Biopsy‐Guided Versus Clinically Guided Strategies—A Meta‐Analysis

Yongqi Dong iD, Dan Zhou iD, Leyu Zhou iD, Li Yang iD, Yi Shen iD

Liver International · 2026

DOI: 10.1111/liv.70642 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Liver International, 2026. Verfasst von Yongqi Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, and Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital, Sichuan University, …. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Immunosuppressive Agents, Withholding Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐term immunosuppression in autoimmune hepatitis (AIH) carries substantial side effects, making treatment withdrawal an important consideration after sustained biochemical remission. Whether biopsy‐guided withdrawal based on histological assessment reduces relapse compared with clinically guided withdrawal remains uncertain. We conducted a systematic review and meta‐analysis to compare relapse rates between these two strategies. This meta‐analysis followed PRISMA 2020. PubMed, Embase, Web of Science, Scopus and the Cochrane Library were searched from inception to identify studies reporting relapse after treatment withdrawal in AIH using biopsy‐guided or clinically guided strategies. Pooled relapse rates were estimated using random‐effects models of transformed proportions. Prespecified subgroup, sensitivity and meta‐regression analyses evaluated the impact of relapse definitions, histological stringency and follow‐up duration. Twelve studies (518 patients) were included. The pooled relapse rate after treatment withdrawal was 51.1%. Relapse rates were not significantly different between biopsy‐guided (48.3%) and clinically guided withdrawal (56.3%; p = 0.604). Studies defining relapse by transaminase elevation alone reported higher relapse rates than those incorporating IgG elevation. Within biopsy‐guided cohorts, stricter histological remission thresholds were associated with lower relapse rates and reduced heterogeneity.Relapse after treatment withdrawal in AIH remained common and did not differ significantly between biopsy‐guided and clinically guided strategies. In the context of existing guideline recommendations, current evidence does not clearly support routine prewithdrawal liver biopsy in all patients with sustained biochemical remission. Trial Registration PROSPERO registration number: 4202511295

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AutoimmuneImmunosuppressive AgentsWithholding TreatmentHumansRecurrenceBiopsyTreatment InterruptionLiverRemission Induction

Stichwörter der Autor:innen

autoimmune hepatitisbiopsyimmunosuppressive treatmentrelapsewithdrawal

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, and Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

ORCID-Profile: Yongqi Dong, Dan Zhou, Leyu Zhou, Li Yang, Yi Shen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dong, Y., Zhou, D., Zhou, L., Yang, L., & Shen, Y. (2026). Relapse After Treatment Withdrawal in Autoimmune Hepatitis: Biopsy‐Guided Versus Clinically Guided Strategies—A Meta‐Analysis. Liver International. https://doi.org/10.1111/liv.70642

Vancouver

Dong Y, Zhou D, Zhou L, Yang L, Shen Y. Relapse After Treatment Withdrawal in Autoimmune Hepatitis: Biopsy‐Guided Versus Clinically Guided Strategies—A Meta‐Analysis. Liver International. 2026. doi:10.1111/liv.70642

BibTeX
@article{Dong2026,
  author = {Dong, Yongqi and Zhou, Dan and Zhou, Leyu and Yang, Li and Shen, Yi},
  title = {Relapse After Treatment Withdrawal in Autoimmune Hepatitis: Biopsy‐Guided Versus Clinically Guided Strategies—A Meta‐Analysis},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70642}
}
Kostenlos starten →